A nutrient combo with scientific documentation
KiSel-10 is the first study of its kind to investigate in detail how the combination of organic selenium yeast and coenzyme Q10 affects the human body at a cellular level.
The two active preparations that were used by the team of scientists are based on decades of scientific collaboration between Pharma Nord and leading scientists in the field of nutrition. They are available as a combined preparation called Bio-SelenoQ10 with 200 micrograms of the patented selenium yeast (SelenoPrecise) and 200 mg of pharmaceutical-grade coenzyme Q10 (Bio-Quinone Q10), exactly like the combination used in the KiSel-10 study.
SelenoPrecise is documented in well over 40 published science studies that validate the superior bioavailability of this selenium yeast with its more than 20 different organic selenium species.
Bio-Quinone Q10, which is Pharma Nord’s unique coenzyme Q10 formulation, is documented in 75 published human studies, 26 of which are gold-standard trials. Both preparations have earned a reputation as highly reliable, pharmaceutical-grade supplements with documented safety, quality, absorbability, and effect.
SelenoPrecise is available as a mono preparation and marketed in a supplement version and a drug version.
Bio-Quinone Q10 is sold as a nutritional supplement but is also available in some countries as a drug (Myoquinone) intended to use as an adjuvant in the treatment of chronic heart failure.